Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
2.040
+0.080 (4.08%)
At close: Jun 5, 2026, 4:00 PM EDT
1.870
-0.170 (-8.33%)
After-hours: Jun 5, 2026, 7:56 PM EDT
Genenta Science Employees
Genenta Science had 9 employees as of December 31, 2025. The number of employees decreased by 4 or -30.77% compared to the previous year.
Employees
9
Change (1Y)
-4
Growth (1Y)
-30.77%
Revenue / Employee
n/a
Profits / Employee
-$851,868
Market Cap
48.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | -4 | -30.77% |
| Dec 31, 2024 | 13 | -1 | -7.14% |
| Dec 31, 2023 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 119 |
| Xilio Therapeutics | 76 |
| aTyr Pharma | 60 |
| RenovoRx | 17 |
| Lantern Pharma | 16 |
| Nutriband | 13 |
| Actuate Therapeutics | 12 |
| Hyperion DeFi | 9 |
GNTA News
- 6 weeks ago - Genenta signs Definitive Agreements with Sophia High Tech - GlobeNewsWire
- 2 months ago - Genenta Science enters binding offer to fund Sophia High Tech - TheFly
- 2 months ago - Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs - GlobeNewsWire
- 2 months ago - Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini - GlobeNewsWire
- 3 months ago - Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University - GlobeNewsWire
- 3 months ago - Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform - GlobeNewsWire
- 4 months ago - Genenta Science to change name to Saentra Forge, seeks controlling stake in ATC - TheFly
- 4 months ago - Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator - GlobeNewsWire